Original release date: October 14, 2021
Access to this course expires on:  September 18, 2024 at 11:59 PM Pacific Time
CME 12.25

Course Description
Cytopathology possesses inherent diagnostic challenges in routine daily practice, compounded in recent years by numerous developments. Novel entities have been described, molecular alterations have been discovered, and multiple major shifts in diagnostic classification schemes have been introduced. It is difficult for pathologists to stay current and maintain proficiency in cytopathology without supplemental training and education.

There is growing demand and expectation by clinicians for pathologists to provide contemporary cytology services in this era of precision medicine, emphasizing cytopathology’s critical role as adjunct to targeted therapies. Accurate diagnosis is paramount to the initiation of appropriate treatment and depends on specific skills, clinical knowledge, awareness of the broad cytomorphologic range and overlap of lesions that may be encountered, and familiarity with ancillary tests.

This course is pragmatic, clinically oriented and stimulating. The selected cases are associated with potential diagnostic challenges and risks in day-to-day practice. Four experts provide an intimate mentoring experience in a superb learning environment that reflects USCAP’s educational standards.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives

Upon completion of this educational activity, learners will be able to:

• Become competent in diagnosing common and uncommon lesions in aspiration and exfoliative cytology
• Establish an algorithmic diagnostic approach to challenging cases including tumors of unknown origin
• Learn about the recent developments in cytology reporting systems and how to apply them in practice
• Learn when to integrate clinical findings and ancillary tests in order to deliver a more precise cytologic diagnosis

Continuing Medical Education

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.25  AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Zahra Maleki, MD, Liron Pantanowitz, MD, Momin T. Siddiqui, MD, FIAC, Eva M. Wojcik, MD

The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: David B. Kaminsky, MD, FIAC

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. View and print your certificate by  clicking here.

Buy the Course and get a great discount! Not A Member? Click Here